BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 18, 2026
See today's BioWorld Asia
Home
» U.S. switches stance on IP waiver, sponsors promise revision
To read the full story,
subscribe
or
sign in
.
U.S. switches stance on IP waiver, sponsors promise revision
May 11, 2021
By
Mari Serebrov
Once again, the World Trade Organization postponed a decision on a temporary IP waiver for COVID-19 vaccines and other related medical products.
BioWorld Asia
Regulatory
Vaccine
U.S.
Patents
